Search results
How Hypertrophic Cardiomyopathy Progresses in Adults
Time via Yahoo News· 3 months agoTreatment sometimes involves an implantable defibrillator. Credit - Karsten Eggert—Getty Images Hypertrophic cardiomyopathy is the most common form of...
Dr. Hersh: Hypertrophic cardiomyopathy occurs when heart muscle becomes too thick
The Metrowest Daily News via Yahoo News· 3 months agoHypertrophic cardiomyopathy (HCM) is a condition where some of the heart muscle becomes too thick,...
Cytokinetics (CYTK) Up 83% as Cardiomyopathy Drug Meets Goals
Zacks via Yahoo Finance· 6 months agoCytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in...
Edgewise Therapeutics doses first subject in HCM drug trial
Clinical Trials Arena via Yahoo Finance· 1 month agoUS-based biopharmaceutical company Edgewise Therapeutics has dosed the first subject in the Phase II...
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
Zacks via Yahoo Finance· 5 months agoShares of Cytokinetics, Incorporated CYTK increased 15.29% after reports of a plausible acquisition...
Cytokinetics Posts Aficamten Data In Patients With Thickened Heart Muscle
Benzinga via Yahoo Finance· 1 year agoCytokinetics Incorporated (NASDAQ: CYTK) presented results from Cohort 4 of REDWOOD-HCM Phase 2...
Bristol Myers (BMY) Gets FDA Nod for Data Addition to Camzyos
Zacks via Yahoo Finance· 12 months agoBristol Myers Squibb BMY announced that the FDA approved the supplemental new drug application...
Bristol Myers (BMY) Up 14.6% YTD: Will the Performance Continue?
Zacks via Yahoo Finance· 2 years agoShares of Bristol Myers BMY have gained 14.6% in the year so far against the industry’s decline of...
Will Bristol Myers (BMY) Gain From New Drugs' Label Expansion?
Zacks via Yahoo Finance· 1 year agoBristol-Myers Squibb BMY has recently been enjoying a string of positive regulatory updates. The...
Biotech Stock Roundup: SRPT's DMD Therapy Approval, ICPT's Setback & More Updates
Zacks via Yahoo Finance· 12 months agoIt was a busy week for the biotech sector. Key regulatory and pipeline updates from Sarepta...